UBS analyst Andrew Jones downgraded Nucor (NUE) to Neutral from Buy with a price target of $183, up from $168.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUE:
- Nucor: Mixed Q4 Performance and In-Line Outlook Justify Neutral Hold Rating
- Closing Bell Movers: Heath insurers slide on lower CMS rate increase plan
- Nucor Announces Q4 2025 Earnings and Dividend Declaration
- Nucor reports Q4 adjusted EPS $1.73, consensus $1.77
- Nucor expects Q1 earnings to increase vs. Q4